These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23732944)

  • 1. Lipid-based intravesical drug delivery systems with controlled release of trospium chloride for the urinary bladder.
    Haupt M; Thommes M; Heidenreich A; Breitkreutz J
    J Control Release; 2013 Sep; 170(2):161-6. PubMed ID: 23732944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term floating control-released intravesical preparation of 5-fluorouracil for the local treatment of bladder cancer.
    Wang LH; Shang L; Shan DY; Che X
    Drug Dev Ind Pharm; 2017 Aug; 43(8):1343-1350. PubMed ID: 28402146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Once-daily trospium chloride 60 mg extended-release provides effective, long-term relief of overactive bladder syndrome symptoms.
    Zinner NR; Dmochowski RR; Staskin DR; Siami PF; Sand PK; Oefelein MG
    Neurourol Urodyn; 2011 Sep; 30(7):1214-9. PubMed ID: 21462240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical properties and in vivo bioavailability in human volunteers of isradipine using controlled release matrix tablet containing self-emulsifying solid dispersion.
    Tran PH; Tran TT; Piao ZZ; Vo TV; Park JB; Lim J; Oh KT; Rhee YS; Lee BJ
    Int J Pharm; 2013 Jun; 450(1-2):79-86. PubMed ID: 23612354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid lipid extrusion of sustained release dosage forms.
    Reitz C; Kleinebudde P
    Eur J Pharm Biopharm; 2007 Sep; 67(2):440-8. PubMed ID: 17481868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trospium chloride treatment of overactive bladder.
    Biastre K; Burnakis T
    Ann Pharmacother; 2009 Feb; 43(2):283-95. PubMed ID: 19193592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticholinergic burden and comorbidities in patients attending treatment with trospium chloride for overactive bladder in a real-life setting: results of a prospective non-interventional study.
    Ivchenko A; Bödeker RH; Neumeister C; Wiedemann A
    BMC Urol; 2018 Sep; 18(1):80. PubMed ID: 30217174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once-daily administration of trospium chloride extended release provides 24-hr coverage of nocturnal and diurnal symptoms of overactive bladder: an integrated analysis of two phase III trials.
    Ginsberg DA; Oefelein MG; Ellsworth PI
    Neurourol Urodyn; 2011 Apr; 30(4):563-7. PubMed ID: 21268101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of trospium chloride therapy on intraocular pressure and tear secretion in overactive bladder patients.
    Turkoglu AR; Parmak Yener N; Coban S; Guzelsoy M; Emul A; Demirbas M; Demirci H
    Cutan Ocul Toxicol; 2017 Dec; 36(4):331-335. PubMed ID: 28468509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MALDI-TOF MS imaging of controlled release implants.
    Kreye F; Hamm G; Karrout Y; Legouffe R; Bonnel D; Siepmann F; Siepmann J
    J Control Release; 2012 Jul; 161(1):98-108. PubMed ID: 22551600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once daily trospium chloride is effective and well tolerated for the treatment of overactive bladder: results from a multicenter phase III trial.
    Staskin D; Sand P; Zinner N; Dmochowski R;
    J Urol; 2007 Sep; 178(3 Pt 1):978-83; discussion 983-4. PubMed ID: 17632131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and characterization of extended release Kollidon SR mini-matrices prepared by hot-melt extrusion.
    Ozgüney I; Shuwisitkul D; Bodmeier R
    Eur J Pharm Biopharm; 2009 Sep; 73(1):140-5. PubMed ID: 19406237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trospium chloride once-daily extended release is efficacious and tolerated in elderly subjects (aged ≥ 75 years) with overactive bladder syndrome.
    Sand PK; Johnson Ii TM; Rovner ES; Ellsworth PI; Oefelein MG; Staskin DR
    BJU Int; 2011 Feb; 107(4):612-20. PubMed ID: 20707790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of once-daily trospium chloride extended-release in male patients with overactive bladder.
    MacDiarmid SA; Ellsworth PI; Ginsberg DA; Oefelein MG; Sussman DO
    Urology; 2011 Jan; 77(1):24-9. PubMed ID: 20970833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Trospium Chloride on Cognitive Function in Women Aged 50 and Older: A Randomized Trial.
    Geller EJ; Dumond JB; Bowling JM; Khandelwal CM; Wu JM; Busby-Whitehead J; Kaufer DI
    Female Pelvic Med Reconstr Surg; 2017; 23(2):118-123. PubMed ID: 28067745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melt extruded helical waxy matrices as a new sustained drug delivery system.
    Hasa D; Perissutti B; Grassi M; Zacchigna M; Pagotto M; Lenaz D; Kleinebudde P; Voinovich D
    Eur J Pharm Biopharm; 2011 Nov; 79(3):592-600. PubMed ID: 21827851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trospium chloride for the treatment of overactive bladder with urge incontinence.
    Singh-Franco D; Machado C; Tuteja S; Zapantis A
    Clin Ther; 2005 May; 27(5):511-30. PubMed ID: 15978301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathologic and Urodynamic Effects of the Anticholinergic Drugs Oxybutynin, Tolterodine, and Trospium on the Bladder.
    Orgen S; Deliktas H; Sahin H; Gedik A; Nergis Y
    Low Urin Tract Symptoms; 2017 Jan; 9(1):52-56. PubMed ID: 28120444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of trospium for prevention of catheter-related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study.
    Srivastava VK; Agrawal S; Deshmukh SA; Noushad F; Khan S; Kumar R
    Korean J Anesthesiol; 2020 Apr; 73(2):145-150. PubMed ID: 31602966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of pH-independent sustained release tablet containing solid dispersion granules of a poorly water-soluble drug.
    Tran HT; Park JB; Hong KH; Choi HG; Han HK; Lee J; Oh KT; Lee BJ
    Int J Pharm; 2011 Aug; 415(1-2):83-8. PubMed ID: 21641985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.